Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer


Acquired | Acquired

About Vitatex

Vitatex is a biotech company, focused on commercializing rare cell-enrichment research and diagnostic products. The company believe that the company's products can provide R&D and clinical benefits. The company's products help researchers obtain target cells, genes and gene products that may help develop new diagnostic and therapeutic products.

Vitatex Headquarter Location

25 Health Sciences Drive Suite 220 124

Stony Brook, New York, 11790,

United States


Latest Vitatex News

GoodMills Innovation Raises the Sensory Qualities of Alt Meat & Fish to a “New Level” With VITATEX Texturates

Sep 27, 2021

Germany’s GoodMills Innovation, part of the GoodMills Group, Europe’s leading milling corporation, introduces VITATEX texturates based on wheat, soy and peas, for fish and meat substitute products. The company states that the texturates are perfect for alt seafood products such as plant-based tuna, fish fingers, pan- or deep-fried fish, and are optimally suited for the frozen food sector. “Whether it’s fish & chips, fish fingers or fishcakes, all of these specialities can be readily converted into vegan form with VITATEX®”, says the Hamburg based firm. As well as the applications in seafood alternatives, the texturates can be applied to alt meat products such as vegan patties, meatballs, Bolognese sauce, chicken nuggets, Vienna sausages, or schnitzels. After working with wheat texturates for around a decade, GoodMills Innovation claims it has now succeeded in raising the sensory qualities of fish and meat substitute products to a new level with the use of new extrusion technology and the addition of soy and peas as raw materials. “Our secret is Meat Mimicking: we analyse the sensory profile of the original product in the deepest detail – and then replicate it in meat-free form, using 100 per cent natural, clean-label ingredients. Our results are so astonishing that we even convince the most critical sensory panels. We’re very proud of that, believe us!” ...

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.